Nanobiotix (NBTX) Financial Statements

116 Followers

Nanobiotix Financial Overview

Nanobiotix's market cap is currently $2.01B. The company's EPS TTM is $-0.5; its P/E ratio is -67.36; Nanobiotix is scheduled to report earnings on May 20, 2026, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Mar 23	Dec 21
Income Statement
Total Revenue	€ 29.64M	€ -7.19M	€ 36.21M	€ 4.78M	€ 2.65M
Gross Profit	€ 29.64M	€ -7.19M	€ 36.21M	€ 4.78M	€ 2.65M
Operating Income	€ -10.82M	€ -68.39M	€ -26.78M	€ -46.70M	€ -52.58M
EBITDA	€ -12.07M	€ -67.67M	€ -23.69M	€ -44.22M	€ -45.60M
Net Income	€ -23.96M	€ -68.13M	€ -39.70M	€ -57.04M	€ -47.00M
Balance Sheet
Cash & Short-Term Investments	€ 52.75M	€ 49.74M	€ 75.28M	€ 41.39M	€ 84.17M
Total Assets	€ 67.76M	€ 67.42M	€ 93.90M	€ 59.77M	€ 101.77M
Total Debt	€ 95.32M	€ 50.90M	€ 50.56M	€ 53.17M	€ 46.02M
Net Debt	€ 42.57M	€ 1.17M	€ -24.72M	€ 11.78M	€ -37.90M
Total Liabilities	€ 152.24M	€ 133.12M	€ 95.74M	€ 86.81M	€ 74.98M
Stockholders' Equity	€ -84.48M	€ -65.70M	€ -1.84M	€ -27.05M	€ 26.79M
Cash Flow
Free Cash Flow	€ -33.97M	€ -20.40M	€ -12.80M	€ -37.20M	€ -30.10M
Operating Cash Flow	€ -33.42M	€ -19.55M	€ -12.48M	€ -37.10M	€ -29.87M
Investing Cash Flow	€ -578.00K	€ -955.00K	€ -349.00K	€ 138.00K	€ -242.00K
Financing Cash Flow	€ 37.42M	€ -5.13M	€ 46.77M	€ -5.65M	€ -5.18M

Currency in EUR

Nanobiotix Earnings and Revenue History

Income Statement >

Nanobiotix Debt to Assets

Balance Sheet >

Nanobiotix Cash Flow

Cash Flow >

Nanobiotix Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >